Spironolactone impurity D
| Product Name | Spironolactone impurity D |
|---|---|
| Alternate Names | Spironolactone Impurities, Impurities of Spironolactone |
| CAT No. | CS-O-10706 |
| CAS No. | Not Available |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 448.64 g/mol |
| Mol. For. | C₂₄H₃₂O₄S₂ |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Spironolactone |
| Purity | 98.4 |
| Therapeutic | Anti-Hypertensives |
| Smileys | C[C@@]12[C@](OC3=O)(CC3)CC[C@@]1([H])[C@@]([C@@H](CC4=CC5=O)SSC(C)=O)([H])[C@]([C@]4(CC5)C)([H])CC2 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Spironolactone is a medication that is commonly used to treat hypertension, edema, and other conditions related to fluid retention. However, during the manufacturing process, impurities may be generated that can affect the purity and effectiveness of the drug. One such impurity is Spironolactone Impurity D.
Spironolactone Impurity D, also known as 7α-thiomethylspironolactone, is a byproduct of the synthesis of Spironolactone. This impurity is usually present in small amounts in Spironolactone formulations, and its levels are closely monitored during the manufacturing process to ensure that they do not exceed regulatory limits.
From a chemical perspective, Spironolactone Impurity D is a derivative of Spironolactone that contains a sulfur atom and a methyl group attached to the 7α position of the steroid nucleus. This impurity is structurally similar to Spironolactone, but it has a slightly different pharmacological profile.
While Spironolactone Impurity D is not itself an active pharmaceutical ingredient, it can still affect the safety and efficacy of Spironolactone formulations. Therefore, it is important to carefully control the levels of this impurity during the manufacturing process and to monitor its presence in finished products.
Get an Instant Quote
Related Compounds
Spironolactone acid | Spironolactone EP impurity I | Spironolactone EP impurity B | Spironolactone Impurity 2 | Spironolactone EP impurity G | Spironolactone EP impurity C | Spironolactone EP impurity E | Spironolactone Epimer Mixture | Spironolactone impurity H | Spironolactone EP impurity A |